Bradenton, Florida Clinical Trials

A listing of Bradenton, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 206 clinical trials
Study to Evaluate a Single Dose of STI-2020 (COVI-AMG ) in Adults With Mild COVID-19 Symptoms

This study investigates the safety, pharmacokinetic (PK) profile and efficacy of a single injection of COVI-AMG in outpatient adults with mild COVID-19 symptoms.

Synergy Healthcare LLC
 (7.0 away) Contact site
  • 22 Apr, 2021
  • +3 other locations
A Study of ERAS-007 in Patients With Advanced or Metastatic Solid Tumors

To evaluate the safety and tolerability of ERAS-007 monotherapy administered once weekly (QW) and twice daily-once weekly (BID-QW). To determine the Maximum Tolerated Dose (MTD) and/or Recommended Dose (RD) of ERAS-007 monotherapy administered BID-QW. To characterize the pharmacokinetic (PK) profile of ERAS-007 monotherapy. To determine the optimal dose and schedule …

Sarah Cannon Research Institute (Florida Cancer Specialists)
 (4.8 away) Contact site
  • 30 May, 2021
  • +4 other locations
A Study of TNB-585 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

This is a phase 1, open-label study evaluating the safety, clinical pharmacology and clinical activity of TNB-585, a PSMA x CD3 T-cell engaging bispecific antibody, in subjects with metastatic castrate-resistant prostate cancer (mCRPC) who have received 2 or more prior lines of therapy. The study consists of 2 parts, a …

Florida Cancer Specialists
 (5.4 away) Contact site
  • 26 May, 2021
  • +2 other locations
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is a double-blind, randomized trial with one dose of ALZ-801 compared to placebo.

Bradenton Research Center
 (8.8 away) Contact site
  • 15 Jun, 2021
  • +38 other locations
Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer

The purpose of this trial is to investigate the safety and tolerability of TAS3681, to find the maximum tolerated dose (MTD)/recommended dose of TAS3681 (Escalation Phase) and to further evaluate safety and preliminary efficacy of TAS3681 at the MTD/recommended dose (Expansion Phase).

Sarah Cannon Research Institute
 (5.4 away) Contact site
  • 16 May, 2021
  • +10 other locations
Assessment of the GORE EXCLUDER Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

The purpose of the study is to assess the safety and effectiveness of the GORE EXCLUDER Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal aorta. Performance of the GORE EXCLUDER Conformable AAA Endoprosthesis will be judged by separate performance goals.

aortic aneurysm
Sarasota Vascular Specialists
 (5.4 away) Contact site
  • 15 Jun, 2021
  • +49 other locations
Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression Agitation and Irritability in Patients With Traumatic Brain Injury

This is a multicenter, randomized, placebo-controlled study to evaluate AVP-786 for the treatment of neurobehavioral disinhibition including aggression, agitation, and irritability in participants with traumatic brain injury (TBI).

Roskamp Institute Clinic, Inc.
 (3.7 away) Contact site
  • 04 Jun, 2021
  • +83 other locations
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

The study is a multi-center, un-blinded, randomized control study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.

Sarasota Memorial Health Care System
 (6.9 away) Contact site
  • 23 Jun, 2021
  • +48 other locations
Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain

To evaluate the efficacy of three doses of quinagolide administered as an extended-release vaginal ring compared to placebo on reduction of moderate to severe endometriosis-related pain

Physician Care Clinical Research
 (7.1 away) Contact site
  • 14 May, 2021
  • +55 other locations
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

A double-blind placebo controlled randomized Phase 3 study to determine if 80 or 100 mg of MGL-3196 as compared with placebo resolves NASH on liver biopsy and prevents progression to cirrhosis and/or advanced liver disease

liver disease
ballooning degeneration
Florida Research Institute
 (2.6 away) Contact site
  • 12 Mar, 2021
  • +219 other locations